Lyell Immunopharma corrects Executive Chairman Klausner's resignation effective date to Oct 1, 2021

Lyell Immunopharma, Inc.

Original 8-K had a typo; resignation date corrected to October 1, 2021.
Dr. Richard Klausner resigns as Executive Chairman and employee, effective October 1, 2021.
No other changes made to the original disclosure.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Richard Klausner

Executive Chairman

LYEL · Lyell Immunopharma, Inc.

Effective: 2021-10-01
Filed: October 1, 2021, 7:59 PM ET

On September 29, 2021, Dr. Klausner informed the Company that he will be resigning from his position as Executive Chairman of the Company and will no longer be an employee, effective October 1, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Richard Klausner resigned as Executive Chairman at Lyell Immunopharma, Inc..

Action: resigned
Role: Executive Chairman

Exact text from the filing

On September 29, 2021, Dr. Klausner informed the Company that he will be resigning from his position as Executive Chairman of the Company and will no longer be an employee, effective October 1, 2021.

View on SEC.gov

Lyell Immunopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-288697

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.